P4-01-18: AP-1 Blockade Potentiates the Anti-Tumor Effect of Endocrine Treatment and Reverts the Resistant Phenotype in Hormone Receptor-Positive Breast Cancer.

Livia Malorni, Rachel Schiff, HH He et al.|Cancer Research|2011

Cited by 1